Treatment of Listeria Monocytogenes Infection

Standard Treatment Regimens

The American College of Physicians recommends high-dose intravenous ampicillin (or amoxicillin) in combination with gentamicin as the first-line treatment for invasive Listeria monocytogenes infection, with trimethoprim-sulfamethoxazole (TMP-SMX) as the preferred alternative for penicillin-allergic patients 1
Ampicillin plus gentamicin remains the treatment of choice for invasive listeriosis, including meningitis and bacteremia, providing synergistic bactericidal activity 1

The Infectious Diseases Society of America recommends trimethoprim-sulfamethoxazole as the preferred alternative for penicillin-allergic patients 1

Pregnant women face 10-17 times higher risk of invasive listeriosis compared to the general population, accounting for 17-33% of all cases, and should be treated with safe antibiotics including ampicillin, cefotaxime, ceftriaxone, or TMP-SMX 1, 2
Fluoroquinolones must be strictly avoided during pregnancy 1
Extraintestinal spread during pregnancy can lead to placental and amniotic fluid infection, resulting in pregnancy loss 3
HIV-infected pregnant women face compounded risk from both conditions and should follow listeriosis prevention recommendations 3, 4
Patients with low CD4+ counts are at particularly high risk for severe disease 2
Patients on immunosuppressive therapy (especially anti-TNF agents) are at higher risk for severe Listeria infections, and immunosuppressive therapy should be temporarily withheld until resolution of active infection 1

Comprehensive investigation including lumbar puncture should be performed promptly when Listeria infection is suspected in high-risk individuals, and diagnosis requires appropriate microbiological blood and cerebrospinal fluid Gram staining and bacterial cultures 1